News stories about VWR Corporation (NASDAQ:VWR) have trended positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. VWR Corporation earned a media sentiment score of 0.29 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 47.1322758750217 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:
- Stocks Under Scanner in the Medical Research Space — PRA Health Sciences, VWR Corp., Quest Diagnostics, and Laboratory Corp. of America (bizjournals.com)
- Biobanking Market – Global Forecast to 2022 – New Study Released (reports.pr-inside.com)
- Tracking John Paulson’s Paulson & Company Portfolio – Q3 2017 Update (seekingalpha.com)
- Reviewing VWR Corporation (VWR) & Its Peers (americanbankingnews.com)
- VWR Corporation (VWR) Short Interest Down 41.9% in October (americanbankingnews.com)
Several brokerages recently issued reports on VWR. BidaskClub cut shares of VWR Corporation from a “sell” rating to a “strong sell” rating in a report on Thursday, July 27th. Zacks Investment Research raised shares of VWR Corporation from a “hold” rating to a “buy” rating and set a $37.00 target price for the company in a report on Wednesday, August 2nd. Finally, ValuEngine raised shares of VWR Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, September 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $31.67.
VWR Corporation (NASDAQ:VWR) last released its quarterly earnings data on Tuesday, November 7th. The medical research company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.08. VWR Corporation had a net margin of 3.27% and a return on equity of 15.90%. The company had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.16 billion. During the same quarter in the previous year, the company earned $0.44 earnings per share. The firm’s revenue for the quarter was up 5.2% on a year-over-year basis. analysts predict that VWR Corporation will post 1.85 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.com-unik.info/2017/11/20/vwr-corporation-vwr-receiving-positive-press-coverage-report-shows.html.
VWR Corporation Company Profile
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
What are top analysts saying about VWR Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for VWR Corporation and related companies.